Colorectal Cancer An overview Dr. Christina Ng MBBS (Melb) FRACP Consultant Medical Oncologist Pantai Medical Center Sunway Medical Center President and Founder of EMPOWERED - PowerPoint PPT Presentation

About This Presentation
Title:

Colorectal Cancer An overview Dr. Christina Ng MBBS (Melb) FRACP Consultant Medical Oncologist Pantai Medical Center Sunway Medical Center President and Founder of EMPOWERED

Description:

Let s now turn our attention to the Epidermal Growth Factor Receptor which is expressed in a ... head and neck and lung cancer. Expression of EGFR has been ... – PowerPoint PPT presentation

Number of Views:460
Avg rating:3.0/5.0
Slides: 42
Provided by: empowered1
Category:

less

Transcript and Presenter's Notes

Title: Colorectal Cancer An overview Dr. Christina Ng MBBS (Melb) FRACP Consultant Medical Oncologist Pantai Medical Center Sunway Medical Center President and Founder of EMPOWERED


1
Colorectal CancerAn overviewDr. Christina Ng
MBBS (Melb) FRACPConsultant Medical
OncologistPantai Medical CenterSunway Medical
CenterPresident and Founder of EMPOWERED
2
What is cancer?
  • Cancer is a group of diseases characterised by
    uncontrolled growth and spread of abnormal cells
  • Cancer is caused by both external factors and
    internal factors that may act together or in
    sequence to initiate or promote carcinogenesis
  • The development of most cancers requires multiple
    steps that occur over many years

Garcia M et al. Global Cancer Facts Figures
2007. Atlanta, GA American Cancer Society, 2007
3
On average, one in three people will be affected
by cancer at some stage in their life
Cancer isnt one disease but many all have
similar features, but each has distinctive
characteristics that vary according to the type
of cancer and its location in the body
In 2000, there were 330,000 new cases of
colorectal cancer and 155,000 deaths in the five
major European countries and the USA
1.2 million cases of breast cancer are diagnosed
across the world each year
Lung cancer is the major cause of cancer death in
the world, accounting for more than 1.2 million
deathseach year
Five European countries listed as France,
Germany, Italy, Spain, UK
4
  • LETS TALK ABOUT COLORECTAL CANCER

5
What is the burden of cancer in Malaysia?2003
Malaysia Ten Most Frequent Cancer Cases
31 Breast 12.9 Cervix Uteri 10.1 Colon
Rectum 4.3 Uterine corpus 4.1 Ovary
4 Leukemia 3.8 Lung 2.9 Stomach 2.7 Othe
r Skin
Colon Rectum 14.2 Lung 13.8 Nasopharynx 8.8
Leukemia 7.1 Prostate Gland 6.4 Stomach 5.1 Lym
phomas 4.3 Other skin 4 Liver 4
Source National Cancer Registry, 2003.
6
5-year survival rates for some cancers have
improved significantly
     
1995-2000
Today
Site
1974-1976
1983-1985
  • All sites 50 53 64 gt68
  • Breast (female) 75 78 88 gt90
  • Colon 50 58 63 gt65
  • Leukemia 34 41 46 gt48

These improvements are due to a mix of earlier
detection and advances in treatment, and are
continuing to improve today - especially in more
advanced disease due to new biological therapies
Source (Figures to 2000) Surveillance,
Epidemiology, and End Results Program, 1975-2001,
National Cancer Institute, 2004. 2006 Figures
are estimates based on expert opinion in the
literature
7
How does cancer develop?
  • Cell division in the body
  • All the time, somewhere in our bodies there is a
    need for new cells
  • Normal cells divide, get old and die
  • This process is usually ordered and highly
    controlled

8
Cell division in the body
Normal cell division
  • Cancer develops when abnormal cells grow out of
    control.
  • These cells grow until a lump or tumour is forms.

9
How quickly cancer grows?
  • Tumor growth rate is time it takes to double in
    size.
  • It takes 30 doublings to produce a 1cm tumor.
  • Therefore, if the doubling time of a tumor is
    around 75 days, 30 doublings will take more than
    6 years.
  • This means a tumor may have been growing for
    several years before detection. During this
    time, symptoms may be vague and not noticed.

10
How Colorectal Cancer Develops
  • Cancer of colon and rectum (also called
    colorectal cancer) arise from the inner wall of
    the large intestine.
  • The first 6 feet of the large intestine makes up
    the large bowel or colon.
  • The final 6 inches make up the rectum and the
    anal canal.
  • Cancer cells can break away and spread to other
    parts of the body (liver and lung).

National Cancer Institute Website Colorectal
Cancer
11
Risk Factors
12
Risk Factors
  • Risk factors include the following
  • Age 50 or older
  • A family history of cancer of the colon or rectum
  • A history of polyps in the colon
  • A history of ulcerative colitis (ulcers in the
    lining of the large intestine)
  • Certain hereditary conditions
  • Diet

American Cancer Society Website
13
How Is Colorectal Cancer Diagnosed?
  • Medical history and physical exam including
    digital rectal exam
  • Faecal Occult Blood
  • Sigmoidoscopy, barium enema, double-contrast
    barium enema, colonoscopy

14
Other Tests
  • Blood tests including tumour markers
  • substances in the blood that can help tell how
    well treatment is working
  • not used to find cancer in people who have not
    had cancer and who appear to be healthy rather,
    they are most often used for follow-up of people
    who have already been treated
  • Biopsy
  • Ultrasound and Chest x-ray
  • Computed tomography (CT)
  • Magnetic resonance imaging (MRI)
  • Positron emission tomography (PET

15
Signs Symptoms
  • Early stages of colon cancer may not have any
    symptoms.
  • As the polyp grows into a tumor, it may bleed or
    obstruct the colon, causing symptoms. These
    symptoms include
  • Bleeding from the rectum
  • Blood in the stool or toilet after a bowel
    movement
  • Changes in bowel habits such as diarrhea or
    constipation
  • Feeling of still needing the toilet after having
    emptied the bowel
  • Cramping pain in the abdomen
  • General abdomen discomfort (frequent gas pains,
    bloating, fullness, or cramps) or vomiting
  • Weight loss with no known reason
  • Constant tiredness.

1Cancer Facts Figures, 2007. American Cancer
Society
16
Stages1
  • Stage I The cancer is in the inner layers of the
    colon
  • Stage II The cancer has spread through the
    muscle wall of the colon
  • Stage III The cancer has spread to the lymph
    nodes
  • Stage IV The cancer that has spread to other
    organs (metastasis)

1Dukes, C. The classification of cancer of the
rectum. J Pathol and Bacteriol 193235323-332.
17
American Joint Committee on staging for
Colorectal Cancer
TNM Dukes 5-year survival
Stage I A, B1 8595
Stage II B2 6080
Stage III C 3060
Stage IV D lt5
Macdonald JS. CA Cancer J Clin 1999 49202-219
18
Is Colorectal Cancer Curable?
  • Early detection increase the potential for cure

Most patients who have their cancer diagnosed
early in stage I and 2 (confined to the organ of
origin) or stage 3 (only the first station of
nodes are involved) are cured by existing
modalities and technologies1
1www.radiologymalaysia.org
19
Colorectal Cancer Treatment Options
  • Surgery
  • Radiotherapy
  • Systemic Therapies
  • Chemotherapy
  • Targeted therapy
  • Best supportive care

20
Chemotherapy
  • Compared to most normal cells, cancer cells
    divide much more rapidly
  • Chemotherapy enters the bloodstream and damages
    dividing cells
  • Therefore cancer cells, which are often in the
    process of dividing, are more at risk of being
    damaged by chemotherapy.
  • Chemotherapy kills cells by damaging or
    interrupting the process of cell division.

Reference http//www.cancerresearchuk.org
(Accessed 28/02/2013)
21
Chemotherapy
  • The main ways chemotherapy is administered 
  • An injection into the bloodstream
  • A drip (intravenous infusion) into the
    bloodstream 
  • By mouth (tablets or capsules)
  • The chemotherapy drugs circulate all round the
    body in the bloodstream and can reach cancer
    cells almost anywhere in the body (systemic
    therapy).

Reference http//www.cancerresearchuk.org
(Accessed 28/02/2013)
22
Objectives of Chemotherapy
  • Chemotherapy can be administered at various
    stages of cancer
  • The objectives of chemotherapy can differ
    according to the stage of disease at which it is
    given.
  • Chemotherapy given in the setting of earlier
    stages of disease
  • Neoadjuvant chemotherapy Chemotherapy given
    before surgery to shrink the cancer so that the
    surgical procedure may not need to be as
    extensive
  • Adjuvant chemotherapy Chemotherapy given to
    destroy left-over (microscopic) cancer cells that
    may be present after the tumour is removed by
    surgery.  Adjuvant chemotherapy is given to
    prevent a cancer from coming back. 
  • Chemotherapy given in the setting of advanced
    stage of disease
  • Palliative chemotherapy Chemotherapy given
    specifically to manage symptoms, to optimise
    quality of life and prolong survival

Reference http//chemocare.com (Accessed
11/03/2013)
23
Misconception of cancer treatment1
  • Myth Cancer treatment kills bad cells and good
    cells as well
  • Truth
  • Doctors have several methods of treating cancer
    such as surgery, radiotherapy, chemotherapy and
    targeted therapy.
  • Along with the beneficial effects, all medicines
    may cause side-effects (for any disease,
    including cancer).
  • Most side effects of cancer therapy are
    temporary, reversible and manageable. The
    side-effects can be reduce or control by
    medications.
  • Without treatment, cancer progresses and causes
    great pain, suffering and eventually death.
  • Myth Alternative therapies can cure cancer
  • Truth Cancer treatments need to be rigorously
    tested and scientifically verified to be
    effective. Alternative therapies are not tested
    nor verified to be effective against cancer.

1www.radiologymalaysia.org
24
The way cancer is treated is changing
Tumour site
Tumour histology
Old paradigm Toxic, non selective, chemotherapy
drugs
24
25
Development of Systemic Chemotherapy in
Colorectal Cancer
1980
1985
1990
1995
2000
2005
5-FU
Irinotecan
UFT
Capecitabine
Oxaliplatin
Cetuximab
Bevacizumab
26
Targeted Therapy
  • Monoclonal antibodies, block the growth of cancer
    cells by interfering with specific molecules
    needed for tumour growth and division
  • More effective and tolerable than current
    treatment options as they specifically attack
    cancer cells, leaving the majority of healthy
    cells unharmed
  • Cetuximab is an monoclonal antibody that
    specifically targets a receptor on the cell,
    called the epidermal growth factor receptor EGFR.
  • Bevacizumab exerts an inhibitory effect on tumour
    cell growth, survival, motility, invasion and
    tumour ANGIOGENESIS (blood vessel growth).

1. Committee for Medicinal Products for Human Use
EMEA/CHMP/280402/2008 2NCCN Guideline V.1.2009
27
ANGIOGENESIS
  • Angiogenesis is the growth of new blood vessels
  • Normal angiogenesis
  • Occurs primarily during embryonic development but
    also in some adult physiological processes,
    including wound healing and female reproduction
  • Characterized as focal and of brief duration
  • Tumor angiogenesis
  • Growth of blood vessels from surrounding tissue
    to the tumour
  • Initiated by the release of chemicals from the
    tumour.

28
Angiogenesis is essential to tumour development
  • An independent blood supply is required for a
    tumour to grow beyond 2mm in diameter
  • Larger tumours rely on their vasculature for
    survival and further growth

Small avascular tumour
Tumour
Blood vessels
Large, highlyvascularised tumour
Growthfactors
Ferrara, Henzel. Biochem Biophys Res Commun 1989,
Folkman. NEJM 1971
28
29
What is angiogenesis inhibition?
  • Angiogenesis inhibition (anti-angiogenesis)
    therefore means the suppression of the creation
    of blood vessels
  • An angiogenesis inhibitor is an agent that
    prevents the formation of new blood vessels

30
Epidermal Growth Factor Receptor
(EGFR)Expression in Solid Tumors
  • EGFR is expressed in a variety of solid tumors
    and associated with poor prognosis

Colorectal (CRC)
Lung (NSCLC)
Head neck(SCCHN)
Cunningham et al. N Engl J Med 2004351337-345.
Grandis et al. Cancer 1996781284-1292. Salomon
et al. Crit Rev Oncol Hematol 199519183-232.
Walker, Dearing. Breast Cancer Res Treat
199953167-176.
31
EGFR inhibition via monoclonal antibodies
blocking ligand binding
cetuximab
32
Biomarker in Cancer Treatment
  • Biomarker Definition
  • A measurable DNA and/or RNA characteristic that
    is an indicator of normal biologic processes,
    pathogenic processes, and/or response to
    therapeutic or other interventions1

1FDA biomarker definitions
33
Tailored therapy Role of Biomarkers in the
treatment of Colorectal cancer1,2,3
  • Identification of the presence of specific
    molecules, biomarker in colorectal cancer can
    predict the effectiveness of targeted therapies
  • This breakthrough enable oncologists to select
    the most appropriate treatment for patients from
    the beginning and thus improve their overall
    long-term outcomes.

1Lièvre A, et al. J Clin Oncol 200826374379
2VDe Roock W, et al. Ann Oncol 2007Nov 12
3Tabernero J, et al. ASCO GI 2008 Abstract
No435
34
What is KRAS?
  • KRAS is the first and important biomarker for
    metastatic colorectal cancer. KRAS is the
    predictive marker for cetuximab efficacy
  • Higher response rate
  • Trend towards improved survival

Van Cutsem E et al, ASCO 2008
35
Example of Tailored Therapy Presence of the
KRAS-mutation
  • Approximately 40 of colorectal cancer have a
    mutated KRAS gene
  • When the disease progresses, the normal gene may
    change and alters the way signals are
    communicated inside the cancer cell
  • Certain targeted therapies have demonstrated
    improved benefit when combined with standard
    chemotherapy in patients without this mutation
    (known as KRAS wild type)
  • On the other hand, patients with this mutation
    will not benefit from these targeted therapies
  • As such, KRAS testing is often done in patients
    with advanced colorectal cancer to determine the
    best course of treatment for patients

Reference http//fightcolorectalcancer.org/awaren
ess/treatment/personalizing_treatment/kras_mutatio
ns (Accessed 15/03/2013)
36
Conclusion
  • Patients have more treatment choices today
  • Early detection increases the chance of cure
  • The evolving colorectal cancer treatments improve
    the survival in colorectal cancer patients
  • Biomarker can predict the patients response to
    targeted therapies
  • Future studies to explore more predictive
    biomarkers in the cancer treatment to identify
    the right patient to receive tailored targeted
    therapy

37
QUIZ 1
  • Colorectal Cancer
  • Cancer of the colon and rectum
  • The commonest cancer in men
  • 3rd commonest cancer in women
  • Can be present without any symptons
  • Cannot be cured even it is detected early

38
QUIZ 2
  • What are the risk factors of colorectal cancer?
  • Family history of colorectal cancer
  • Presence of polyps
  • Excessive sunlight exposure
  • Cigarette Smoking
  • Age above 50

39
QUIZ 3
  • What are the symptoms of colorectal cancer?
  • Passing blood in the stool
  • Abdominal pain
  • Headache
  • Weight loss
  • Change in bowel habit

40
QUIZ 4
  • What are the methods used for picking up
    colorectal cancer?
  • Faecal occult blood test
  • Colonoscopy
  • Blood test
  • CT scan
  • Biopsy

41
QUIZ 5
  • What are the ways used for treating colorectal
    cancer?
  • Surgery
  • Chemotherapy
  • Vegetarian diet
  • Traditional medicine
  • Radiotherapy
Write a Comment
User Comments (0)
About PowerShow.com